Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.
The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.